Nautilus Biotechnology Stock Options
| NAUT Stock | USD 0.73 0.02 2.67% |
Nautilus Biotechnology's latest option contracts expiring on September 19th 2025 are carrying combined implied volatility of 4.01. The Nautilus Biotechnology option chain provides detailed quote and price information for the current Nautilus Biotechnology option contracts. It shows all of Nautilus Biotechnology's listed puts, calls, expiration dates, strike prices, and other pricing information.
In The Money vs. Out of Money Option Contracts on Nautilus Biotechnology
Analyzing Nautilus Biotechnology's in-the-money options over time can help investors to take a profitable long position in Nautilus Biotechnology regardless of its overall volatility. This is especially true when Nautilus Biotechnology's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Nautilus Biotechnology's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Nautilus Biotechnology's stock while costing only a fraction of its price.
Nautilus Current Options Market Mood
Nautilus Biotechnology's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Nautilus Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Unfortunately, most Nautilus Biotechnology's options investors are not very successful. Nautilus Biotechnology's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Nautilus contract
Base on the Rule 16, the options market is currently suggesting that Nautilus Biotechnology will have an average daily up or down price movement of about 0.25% per day over the life of the 2025-09-19 option contract. With Nautilus Biotechnology trading at USD 0.73, that is roughly USD 0.00183. If you think that the market is fully incorporating Nautilus Biotechnology's daily price movement you should consider buying Nautilus Biotechnology options at the current volatility level of 4.01%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing Nautilus Biotechnology options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Nautilus calls. Remember, the seller must deliver Nautilus Biotechnology stock to the call owner when a call is exercised.
Nautilus Biotechnology Option Chain
When Nautilus Biotechnology's strike price is surpassing the current stock price, the option contract against Nautilus Biotechnology stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Nautilus Biotechnology's option chain is a display of a range of information that helps investors for ways to trade options on Nautilus. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Nautilus. It also shows strike prices and maturity days for a Nautilus Biotechnology against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | NAUT250919C00007500 | 0 | 7.5 | 0.0 - 0.75 | 0.75 | |
Call | NAUT250919C00005000 | 7 | 5.0 | 0.0 - 0.75 | 0.75 | Out |
Call | NAUT250919C00002500 | 1266 | 2.5 | 0.0 - 0.05 | 0.05 | Out |
Put | NAUT250919P00002500 | 0 | 2.5 | 1.5 - 2.05 | 1.5 | In |
Put | NAUT250919P00005000 | 0 | 5.0 | 4.1 - 4.4 | 4.1 | In |
Put | NAUT250919P00007500 | 0 | 7.5 | 6.5 - 6.9 | 6.5 | In |
Nautilus Total Stockholder Equity
Total Stockholder Equity |
|
Nautilus Biotechnology Corporate Management
| Gwen Weld | Chief Officer | Profile | |
| Parag Mallick | Chief CoFounder | Profile | |
| Sujal Patel | CEO, CoFounder | Profile | |
| Mary Godwin | Senior Operations | Profile | |
| Chris Blessington | Vice Communications | Profile | |
| Subra Sankar | Senior Development | Profile | |
| Kentaro Suzuki | Chief Officer | Profile |
Additional Tools for Nautilus Stock Analysis
When running Nautilus Biotechnology's price analysis, check to measure Nautilus Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nautilus Biotechnology is operating at the current time. Most of Nautilus Biotechnology's value examination focuses on studying past and present price action to predict the probability of Nautilus Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nautilus Biotechnology's price. Additionally, you may evaluate how the addition of Nautilus Biotechnology to your portfolios can decrease your overall portfolio volatility.